Home/Filings/4/0001062993-25-003151
4//SEC Filing

Smeykal Megan 4

Accession 0001062993-25-003151

CIK 0001561921other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 4:16 PM ET

Size

4.9 KB

Accession

0001062993-25-003151

Insider Transaction Report

Form 4
Period: 2025-02-19
Smeykal Megan
Chief Accounting OfficerOther
Transactions
  • Award

    Common Stock

    2025-02-19+9,40039,479 total
Footnotes (2)
  • [F1]Includes 1,079 shares acquired under the Issuer's employee stock purchase plan on July 31, 2024.
  • [F2]These restricted stock units will vest in four equal annual installments beginning on February 19, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates.

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother

Related Parties

1
  • filerCIK 0001899973

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:16 PM ET
Size
4.9 KB